Clinical Trials in Arizona

Showing 7841-7860 of 12,706 trials

Rituximab, Pentostatin, Cyclophosphamide, and Lenalidomide in Treating Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT00602836

RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread. Others find cancer cells and help kill them or carry cancer-killing substances to them. Drugs used in chemotherapy, such as pentostatin and cyclophosphamide, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Lenalidomide may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Giving rituximab together with combination chemotherapy and lenalidomide may kill more cancer cells. PURPOSE: This phase II trial is studying how well giving rituximab together with pentostatin, cyclophosphamide, and lenalidomide works in treating patients with previously untreated B-cell chronic lymphocytic leukemia or small lymphocytic lymphoma.

LeukemiaLymphoma

Mayo Clinic45 participantsStarted Feb 2008

Scottsdale, Arizona, United States • Jacksonville, Florida, United States • Rochester, Minnesota, United States

COMPLETEDPhase 1/231 miles

Lacripep™ in Subjects With Dry Eye Associated With Primary Sjögren's Syndrome

NCT03226444

The objective of this study is to evaluate the efficacy and safety of two strengths of Lacripep™ ophthalmic solution versus placebo administered three times daily for four weeks in subjects with a diagnosis of Dry Eye associated with documented Primary Sjögren's Syndrome

Primary Sjögren SyndromeDry Eye

TearSolutions, Inc.204 participantsStarted Jun 2017

Birmingham, Alabama, United States • Scottsdale, Arizona, United States • Scottsdale, Arizona, United States +32 more locations

Rituximab, Pentostatin, Cyclophosphamide, and Lenalidomide in Treating Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Lacripep™ in Subjects With Dry Eye Associated With Primary Sjögren's Syndrome

Find Trials by Condition in Arizona

Understanding the Relationship Between Inflammation and Insulin Resistance in the Adipose Tissue

Evaluation of Glucose Control in Patients With Diabetes

Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone

Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)

Lubiprostone for Children With Constipation

Efficacy and Safety of Semaglutide Versus Canagliflozin as add-on to Metformin in Subjects With Type 2 Diabetes

An Investigation of ReNu™ Knee Injection in Patients With Osteoarthritis

Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia

Safety and Efficacy of IDP-122 in the Treatment of Participants With Plaque Psoriasis

SVRII Family Factors Study

Comparison of a Rivaroxaban-based Strategy With an Antiplatelet-based Strategy Following Successful TAVR for the Prevention of Leaflet Thickening and Reduced Leaflet Motion as Evaluated by Four-dimensional, Volume-rendered Computed Tomography (4DCT)

Study to Investigate the Safety, Tolerability, and Pharmacokinetics of DSTA4637S in Participants With Staphylococcus Aureus Bacteremia Receiving Standard-of-Care (SOC) Antibiotics

Tangible Hydra-PEG: A Promising Solution for Scleral Lens Wearers With Dry Eye

A Study to Look at Tapentadol Oral Solution in Children and Adolescents in Pain

Farber Disease Natural History Study

Rosuvastatin Interethnic PK Study

Validation of Colon Biomarkers for the Early Detection of Colorectal Adenocarcinoma

DELTA Trial: Does Embolization With Larger Coils Lead to Better Treatment of Aneurysms Trial